Posted on: 25 September, 2020
The Kolling Institute’s Executive Director Professor Carolyn Sue will help drive an exciting international project to identify the genetic links to Parkinson’s disease and new ways to treat the debilitating disorder.
Read more
Category: Research Excellence
Posted on: 22 September, 2020
Kolling Institute researchers will help drive an exciting international project to identify the genetic links to Parkinson’s disease and new ways to treat the debilitating disorder.
The program will bring together leading researchers from Sweden, the United States and Australia after a $12.5 million grant from the Aligning Science Across Parkinson’s initiative, which will be administered by the Mic.....
Read more
Category: Funding support
Posted on: 11 September, 2020
With the majority of older Australians taking five or more medications, a team from the Kolling Institute has developed a valuable tool to better understand adverse outcomes.
The analytical resource has been developed by Professor Sarah Hilmer and Dr John Mach, after several years of research investigating the effects of using multiple medications.
Previous studies have generally looked at the inte.....
Read more
Category: Research Excellence
Posted on: 10 September, 2020
A study has been launched to investigate the benefits of a new injectable medication for those with knee osteoarthritis.
The condition can have a profound impact on a person’s life, leading to physical limitations, ongoing pain and joint instability.
There are broader implications too which can make it difficult for those with the condition to engage in social, community and occupational activitie.....
Read more
Category: Musculoskeletal Research, New Treatment
Posted on: 27 August, 2020
With increasing evidence around the benefits of physiotherapy after surgery, a project is set to get underway examining new ways to extend the support.
The BOOST project will investigate how hospitals can deliver more frequent exercise programs for patients with hip fracture, through an innovative model of care involving physiotherapists and other healthcare workers.
The program will be led by the .....
Read more
Category: New Treatment
Posted on: 17 August, 2020
If you have low back pain, you could be the perfect candidate for a new study using text messages to support those with the condition.
Named TEXT4myBACK, the University of Sydney and Kolling Institute study will compare two different formats of text message interventions to help people better manage their symptoms.
Professor Manuela Ferreira would like to see broad participation in the study with l.....
Read more
Category: New Treatment
Posted on: 10 August, 2020
An Australia wide trial is set to get underway with hopes it may lead to life-long improvements for those who experience a spinal cord injury.
Led by Professor Lisa Harvey from the Kolling Institute’s John Walsh Centre for Rehabilitation Research, the study represents a collaboration between the University of Sydney and every spinal injury unit in Australia.
The State Government is investing $2.5 m.....
Read more
Category: Funding support
Posted on: 10 August, 2020
Catherine Storey - Honorary Archivist, Royal North Shore Hospital
One hundred years ago, in 1920, a group of distinguished citizens of NSW devised "a scheme of the utmost importance to NSW, and to the Commonwealth." The world had just emerged from World War 1 and the Spanish flu pandemic of 1919, with a massive loss of life. Research into the common diseases of mankind was seen as a means to r.....
Read more
Category: Newsletters
Posted on: 07 August, 2020
Three valuable research projects have received a boost with the Hillcrest Foundation donating significant funds through the Perpetual IMPACT Philanthropy Program.
The Cancer Genetics team received $75,000 to help uncover genetic drivers for rare neuroendocrine tumours.
Investigator Dr Trish Dwight said these tumours, known as pheochromocytomas and paragangliomas affect a small percentage of the pop.....
Read more
Category: Funding support
Posted on: 06 August, 2020
The prevalence of gout - a form of arthritis characterised by severe pain, redness and joint tenderness has increased across the world at an alarming rate.
That’s according to Kolling Institute researcher Dr Emma Smith, who was the senior author of a research paper analysing the condition from 1990 to 2017.
The paper, published in Arthritis & Rheumatology, found there were more than 41 million .....
Read more
Category: Research Excellence